GFAP and obesity due to melanocortin 4 receptor deficiency: Other studies support the hypothesis that the intermediate filament protein vimentin is involved in obesity and type 2 diabetes, by participating not only in GLUT4 vesicle trafficking but also in lipolysis through an interaction with hormone-sensitive lipase [55,56].